Featured News

COMPANY

Virginia Workforce Award to AMPEL BioSolutions

Virginia Workforce Award to AMPEL BioSolutions

Virginia officials recognized AMPEL BioSolutions for their dedication to identifying, training, and retaining STEM-trained workers, especially in the area of precision medicine. The annual award recognizes Virginia employers who provide high-quality internships to students.

read more
Charlottesville-area company receives praise for internship program

Charlottesville-area company receives praise for internship program

AMPEL BioSolutions, LLC. is being recognized by Virginia officials for its internship program. It is the only tech company in Charlottesville recognized this cycle. AMPEL says its priority is contributing to knowledge of the future. Interns are able to examine RNA, work on projects, and provide design support for doctors

read more
Innovator-of-Year to AMPEL

Innovator-of-Year to AMPEL

CBIC of Virginia honored the  team with “Innovator-of-the-Year” last night June 1st for the AMPEL Genomic Platform of RNA analytics and Machine Learning for dynamic disease management through flare prediction & personalized decision support for drug options. Charlottesville Business Innovation Council (CBIC) presented AMPEL’s “Innovator-of-the-Year” award at the University of Virginia Research Park.

read more

PLATFORM

PRODUCTS

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

Revolutionizing Lupus Care with Advanced Predictive Blood Testing

AMPEL BioSolutions introduces LuGENE®, a cutting-edge blood test poised to revolutionize the management of systematic lupus erythematosus (SLE). LuGENE® leverages predictive artificial intelligence (AI) to detect genetic biomarkers indicative of inflammation-driven SLE flares, offering clinicians valuable insights for tailored treatment strategies.

read more
LuGENE® Lupus Test Launches to Predict Flares & Drug Targets

LuGENE® Lupus Test Launches to Predict Flares & Drug Targets

AMPEL BioSolutions announces a breakthrough in personalized precision medicine that will revolutionize the way doctors manage the autoimmune disease Lupus.  Revealed in the peer-reviewed journal Genome Medicine and being made available to patients through a US follow-on study, the LuGENE® blood test forecasts patient flares and drug targets from gene expression utilizing predictive AI.

read more

PARTNERS

Pin It on Pinterest